Syntal Capital Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Syntal Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $1.54 Million - $1.91 Million	-6,545 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $1.45 Million - $1.71 Million	6,545 New	6,545 $1.71 Million
Q3 2020 Oct 26, 2020	SELL	$255.65 - $303.1 $1.18 Million - $1.4 Million	-4,628 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $1.04 Million - $1.37 Million	4,628 New	4,628 $1.34 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Syntal Capital Partners, LLC with notifications on news.